This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Vedroprevir

Gilead Sciences, Inc.

Drug Names(s): GS-9451, GS9451, GS 9451

Description: GS 9451 is a novel HCV NS3 protease inhibitor with potent in vitro activity against HCV genotype 1 (ranging from 7-10 nM in HCV 1a or 1b replicon assays).


Vedroprevir News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug